Conviction: 4/5
Main thesis
Misc Info
Potential Risks
Main thesis
- Retrace to .786 fib level from 2016 lows. This is an unconventional level but it coincided with medium-term resistance from 2009-2020.
- RSI-W touched historical bounce area (however, if we wait for bullish divergence there could be another leg down)
- RSI-D showing bullish divergence
- Touching lower bound of channel (2016)
Misc Info
- P/S level of 7ish is high on absolute level, but on lower end of range relative to other high growth names
- Healthcare (
XLV) looks good compared to
SPY, could carry this up as well
- High margin and high growth
- Very healthy quick ratio
Potential Risks
- Bullish div = another leg down
- Very negative FCF (not sure why?)
- Channel does not include last major recession (2008)
- General markets are very expensive, and we all know correlation goes to 1 in selloff.
- High growth / expensive names seems like will sell off more than general market
관련 발행물
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
